[Form 4] Hagerty, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Robert I. Kauffman, a director of Hagerty, Inc. (HGTY), reported multiple sales of Class A common stock executed under a Rule 10b5-1 trading plan. The filings show sales on 08/21/2025 (7,356 shares at a weighted average price of $10.77), 08/22/2025 (6,081 shares at $10.92 weighted average) and 08/25/2025 (7,668 shares at $10.87 weighted average). After these transactions the reported beneficial ownership held by Aldel LLC, for which Mr. Kauffman is manager, declined from 1,496,056 shares to 1,482,307 shares, a net reduction of 13,749 shares over the reported dates. The report notes the sales were made pursuant to a 10b5-1 plan adopted August 9, 2024, and that the securities are held of record by Aldel LLC with Mr. Kauffman disclosing voting and investment discretion while disclaiming beneficial ownership except for his pecuniary interest.
Positive
- Transactions executed under a Rule 10b5-1 trading plan, which provides an affirmative defense and indicates pre-planned dispositions.
- Substantial remaining stake: Aldel LLC still reports ownership of 1,482,307 Class A shares after the sales.
Negative
- Insider dispositions totaling 21,105 Class A shares across 08/21/2025–08/25/2025, reducing reported holdings by 13,749 shares from 1,496,056 to 1,482,307.
- Sales executed at prices between approximately $10.67 and $11.02 (weighted averages reported $10.77, $10.92 and $10.87), representing realized insider liquidity.
Insights
TL;DR: Director executed pre-planned sales under a 10b5-1 plan, modestly reducing holdings while retaining substantial position.
The disclosures are consistent with routine, pre-authorized insider sales rather than opportunistic timing: a 10b5-1 plan adopted on August 9, 2024 is cited as the basis for the transactions. The director acts as manager of Aldel LLC, the record holder, and retains voting and investment discretion, which is material to control considerations. The reported net decline of 13,749 Class A shares reduces the recorded Aldel LLC position from 1,496,056 to 1,482,307 shares but leaves a substantial stake intact. This filing does not indicate derivative activity, grants, or other atypical compensation-related transfers; it focuses on ordinary-course dispositions executed in multiple trades at disclosed weighted average prices.
TL;DR: Sales total 21,105 shares across three dates at ~ $10.77–$10.92 weighted prices; impact on float minimal given large remaining stake.
The report documents three specific sell transactions: 7,356 shares (08/21/2025), 6,081 shares (08/22/2025) and 7,668 shares (08/25/2025) executed in multiple trades with reported weighted-average prices. The filings include ranges of execution prices and offer to provide trade-level details upon request. No purchases, options exercises, or derivative transactions are reported. For investors assessing insider activity, these are authorized plan sales rather than discretionary, contemporaneous insider trades.